Clinical & Health Informatics Research Group, Department of Medicine, Biostatistics and Occupational Health, McGill University & McGill University Health Center, 1140 Pine Avenue West, Montreal, QC, H3A 1A3, Canada.
BMC Fam Pract. 2012 Feb 29;13:9. doi: 10.1186/1471-2296-13-9.
Thiazide diuretics are cost-effective for the treatment of mild to moderate hypertension, but physicians often opt for more expensive treatment options such as angiotensin II receptor blockers or angiotensin converting enzyme inhibitors. With escalating health care costs, there is a need to elucidate the factors influencing physicians' treatment choices for this highly prevalent chronic condition. The purpose of this study was to describe the characteristics of physicians' decision-making process regarding hypertension treatment choices.
A comparative qualitative study was conducted in 2009 in the Canadian province of Quebec. Overall, 29 primary care physicians--who are also participating in an electronic health record research program--participated in a semi-structured interview about their prescribing decisions. Physicians were categorized into two groups based on their patterns of prescribing antihypertensive drugs: physicians who predominantly prescribe diuretics, and physicians who predominantly prescribe drug classes other than diuretics. Cases of hypertension that were newly started on antihypertensive therapy were purposely selected from each physician's electronic health record database. Chart stimulated recall interview, a technique utilizing patient charts to probe recall and provide context to physician decision-making during clinical encounters, was used to elucidate reasons for treatment choices. Interview transcripts were synthesized using content analysis techniques, and factors influencing physicians' decision making were inductively generated from the data.
We identified three themes that differentiated physicians who predominantly prescribe diuretics from those who predominantly prescribe other drug classes for the initial treatment of mild to moderate hypertension: a) perceptions about the efficacy of diuretics, b) preferred approach to hypertension management and, c) perceptions about hypertension guidelines. Specifically, physicians had differences in beliefs about the efficacy, safety and tolerability of diuretics, the most effective approach for managing mild to moderate hypertension, and in aggressiveness to achieve treatment targets. Marketing strategies employed by the pharmaceutical industry and practice experience appear to contribute to these differences in management approach.
Physicians preferring more expensive treatment options appear to have several misperceptions about the efficacy, safety and tolerability of diuretics. Efforts to increase physicians' prescribing of diuretics may need to be directed at overcoming these misperceptions.
噻嗪类利尿剂在治疗轻度至中度高血压方面具有成本效益,但医生通常会选择更昂贵的治疗方案,如血管紧张素 II 受体阻滞剂或血管紧张素转换酶抑制剂。随着医疗保健费用的不断增加,有必要阐明影响医生治疗这种高度普遍的慢性疾病的选择的因素。本研究的目的是描述医生治疗高血压选择决策过程的特征。
2009 年,在加拿大魁北克省进行了一项比较定性研究。共有 29 名初级保健医生参与了这项研究,他们也参与了一个电子病历研究项目。这些医生根据他们开降压药的模式被分为两组:主要开利尿剂的医生和主要开利尿剂以外的药物的医生。从每位医生的电子病历数据库中选择新开始抗高血压治疗的高血压病例。使用图表刺激回忆访谈,一种利用患者图表来探究回忆并为医生在临床就诊时的决策提供背景的技术,来阐明治疗选择的原因。使用内容分析技术对访谈记录进行综合,并从数据中归纳出影响医生决策的因素。
我们确定了三个主题,这些主题区分了主要开利尿剂和主要开其他药物类别的医生,用于治疗轻度至中度高血压的初始治疗:a)对利尿剂疗效的看法,b)高血压管理的首选方法,和 c)对高血压指南的看法。具体来说,医生在对利尿剂的疗效、安全性和耐受性的信念、管理轻度至中度高血压最有效的方法以及实现治疗目标的积极性方面存在差异。制药行业的营销策略和实践经验似乎促成了这种管理方法的差异。
选择更昂贵治疗方案的医生似乎对利尿剂的疗效、安全性和耐受性存在一些误解。增加医生开利尿剂处方的努力可能需要针对克服这些误解。